Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-10-10)Premium Content

Novo Nordisk (NVO)

2014-11-20@20:07:12 ET
Novo Nordisk grabs 2nd best position (ABW)

2014-11-20@08:19:51 ET
Relatively Good Performance Detected in Shares of Impax Laboratories in the Pharmaceuticals Industry (IPXL, AZN, NVO, AUXL, RHHBY) (F70)

2014-11-19@17:51:44 ET
Look for Shares of Novo Nordisk to Potentially Pullback after Yesterday's 1.18% Rise (PSM)

2014-11-18@08:39:35 ET
GlaxoSmithKline leads Access to Medicine Index (ABW)

2014-11-18@08:27:50 ET
Bottom 5 Companies in the Pharmaceuticals Industry with the Lowest Relative Performance (JAZZ, NVO, SLXP, POZN, AKRX) (F70)

2014-11-18@01:12:51 ET
US Patent Issued to Novo Nordisk on Nov. 11 for "Single-chain insulin" (Danish Inventors) (ABW)

2014-11-17@12:18:38 ET
Novo Nordisk Crosses Below its 10-day MA (NVO) (F78)

2014-11-17@11:43:23 ET
'Run for Changing Diabetes' (ABW)

2014-11-17@10:00:09 ET
Novo Nordisk Second Best in the World at Providing Access to Medicine (TBL)

2014-11-17@09:25:30 ET
Global Pen Needles Market Report 2014-2019: Type (Standard and Safety), Needle Length (4, 5, 6, 8, 10, 12mm) &Therapy (Insulin, Glucagon-like peptide, Growth Hormones) Analysis (MTO)

2014-11-17@08:19:36 ET
Novo Nordisk A/S - Share repurchase programme (PMZ)

2014-11-17@04:30:31 ET
Human Insulin Market worth $42 Billion by 2019 - Prominent Players are Novo Nordisk (Denmark), Eli Lilly (U.S) & Biocon (India) (MTO)

2014-11-14@14:07:10 ET
Trading Lower on Heavy Volume are Shares of Novo Nordisk on 1.3x Above-Average Volume (NVO) (F82)

2014-11-13@05:59:54 ET
Global Insulin Delivery Devices Market Outlook 2018 (MTO)

2014-11-13@00:50:47 ET
US Patent Issued to Novo Nordisk on Nov. 11 for "Human insulin containing additional disulfide bonds" (Danish Inventors) (ABW)

2014-11-12@08:25:15 ET
Neostem has the Best Relative Performance in the Pharmaceuticals Industry (NBS, SLXP, RPRX, NVO, HSP) (F70)

2014-11-12@08:00:00 ET
Novo Nordisk takes diabetes screening and education to the streets of Philadelphia with the Diabetes Living Room (PRN)

2014-11-12@06:41:05 ET
PharmaPoint: Hemophilia A and B - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update Report (MTO)

2014-11-11@12:38:28 ET
Shares of Novo Nordisk Receive a Boost, Up 1.4% (F77)

2014-11-11@09:05:00 ET
Pharma Equities Technical Data - Salix Pharma, AstraZeneca, Novartis, Impax Laboratories, and Novo Nordisk (PRN)